57 related articles for article (PubMed ID: 38489280)
21. SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.
An Y; Wang B; Wang X; Dong G; Jia J; Yang Q
Cell Death Dis; 2020 Feb; 11(2):115. PubMed ID: 32051395
[TBL] [Abstract][Full Text] [Related]
22. pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks.
Ulgen E; Ozisik O; Sezerman OU
Front Genet; 2019; 10():858. PubMed ID: 31608109
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
24. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
[TBL] [Abstract][Full Text] [Related]
25. Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas.
Hallas-Potts A; Dawson JC; Herrington CS
Sci Rep; 2019 Apr; 9(1):5515. PubMed ID: 30940866
[TBL] [Abstract][Full Text] [Related]
26. Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells.
Faramarzi L; Dadashpour M; Sadeghzadeh H; Mahdavi M; Zarghami N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):737-746. PubMed ID: 30892093
[TBL] [Abstract][Full Text] [Related]
27. Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer.
Li X; Mak VCY; Zhou Y; Wang C; Wong ESY; Sharma R; Lu Y; Cheung ANY; Mills GB; Cheung LWT
Nat Commun; 2019 Feb; 10(1):716. PubMed ID: 30755611
[TBL] [Abstract][Full Text] [Related]
28. Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase.
Wang Z; Dong C
Trends Cancer; 2019 Jan; 5(1):30-45. PubMed ID: 30616754
[TBL] [Abstract][Full Text] [Related]
29. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect and mechanism of metformin on human ovarian cancer cells SKOV-3 and A2780.
Huo J; Bian XH; Huang Y; Miao ZC; Song LH
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):484-489. PubMed ID: 28239823
[TBL] [Abstract][Full Text] [Related]
31. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
[TBL] [Abstract][Full Text] [Related]
33. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
34. Rho GTPases: Regulation and roles in cancer cell biology.
Haga RB; Ridley AJ
Small GTPases; 2016 Oct; 7(4):207-221. PubMed ID: 27628050
[TBL] [Abstract][Full Text] [Related]
35. Ovarian cancer.
Matulonis UA; Sood AK; Fallowfield L; Howitt BE; Sehouli J; Karlan BY
Nat Rev Dis Primers; 2016 Aug; 2():16061. PubMed ID: 27558151
[TBL] [Abstract][Full Text] [Related]
36. Fundamentals of cancer metabolism.
DeBerardinis RJ; Chandel NS
Sci Adv; 2016 May; 2(5):e1600200. PubMed ID: 27386546
[TBL] [Abstract][Full Text] [Related]
37. The effects of metformin and simvastatin on the growth of LNCaP and RWPE-1 prostate epithelial cell lines.
Pennanen P; Syvälä H; Bläuer M; Savinainen K; Ylikomi T; Tammela TLJ; Murtola TJ
Eur J Pharmacol; 2016 Oct; 788():160-167. PubMed ID: 27341997
[TBL] [Abstract][Full Text] [Related]
38. The Function of V-ATPases in Cancer.
Stransky L; Cotter K; Forgac M
Physiol Rev; 2016 Jul; 96(3):1071-91. PubMed ID: 27335445
[TBL] [Abstract][Full Text] [Related]
39. Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.
Yung MM; Ngan HY; Chan DW
Acta Biochim Biophys Sin (Shanghai); 2016 Apr; 48(4):301-17. PubMed ID: 26764240
[TBL] [Abstract][Full Text] [Related]
40. Effect of metformin on apoptosis induction in ovarian cancer cells.
Rogalska A; Forma E; Ciesielski P; Bryś M; Krześlak A; Marczak A
Prz Menopauzalny; 2014 Jun; 13(3):155-61. PubMed ID: 26327848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
